Skip to Main Content

Author Details

Emmie de Wit
National Institute of Allergy and Infectious Diseases, National Institutes of Health
2004
131
53
Kirsten Obernier (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
38079637Replication-Competent Virus Detected in Blood of a Fatal COVID-19 Case.Ann Intern Med2024
36508878Distinct VSV-based Nipah virus vaccines expressing either glycoprotein G or fusion protein F provide homologous and heterologous protection in a nonhuman primate model.EBioMedicine2023
37801035Mechanisms by which the cystic fibrosis transmembrane conductance regulator may influence SARS-CoV-2 infection and COVID-19 disease severity.FASEB J2023
37883246Low level of tonic interferon signalling is associated with enhanced susceptibility to SARS-CoV-2 variants of concern in human lung organoids.Emerg Microbes Infect2023
37684136The neuropathogenesis of highly pathogenic avian influenza H5Nx viruses in mammalian species including humans.Trends Neurosci2023
37356729Late remdesivir treatment initiation partially protects African green monkeys from lethal Nipah virus infection.Antiviral Res2023
36695611Successful lung transplantation using an allograft from a COVID-19-recovered donor: a potential role for subgenomic RNA to guide organ utilization.Am J Transplant2023
34963391Histologic pulmonary lesions of SARS-CoV-2 in 4 nonhuman primate species: An institutional comparative review.Vet Pathol2022
35617976Evaluation of viral load in patients with Ebola virus disease in Liberia: a retrospective observational study.Lancet Microbe2022
35474740Antiviral agents for the treatment of COVID-19: Progress and challenges.Cell Rep Med2022
36517603SARS-CoV-2 infection and persistence in the human body and brain at autopsy.Nature2022
36543806ChAdOx1 NiV vaccination protects against lethal Nipah Bangladesh virus infection in African green monkeys.NPJ Vaccines2022
36399566SARS-CoV-2 Omicron BA.1 and BA.2 are attenuated in rhesus macaques as compared to Delta.Sci Adv2022
35971544SARS-CoV-2 Omicron BA.1 and BA.2 are attenuated in rhesus macaques as compared to Delta.bioRxiv2022
36183296Lessons from the pandemic: Responding to emerging zoonotic viral diseases-a Keystone Symposia report.Ann N Y Acad Sci2022
35039442Age-related differences in immune dynamics during SARS-CoV-2 infection in rhesus macaques.Life Sci Alliance2022
34940844Yearlong COVID-19 Infection Reveals Within-Host Evolution of SARS-CoV-2 in a Patient With B-Cell Depletion.J Infect Dis2022
35032523Subcutaneous remdesivir administration prevents interstitial pneumonia in rhesus macaques inoculated with SARS-CoV-2.Antiviral Res2022
35025969Advances and gaps in SARS-CoV-2 infection models.PLoS Pathog2022
33469217Publisher Correction: ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques.Nature2021
33655261Microbial signatures in the lower airways of mechanically ventilated COVID19 patients associated with poor clinical outcome.medRxiv2021
33791687Microbial signatures in the lower airways of mechanically ventilated COVID19 patients associated with poor clinical outcome.Res Sq2021
33594376Antigen-based multiplex strategies to discriminate SARS-CoV-2 natural and vaccine induced immunity from seasonal human coronavirus humoral responses.medRxiv2021
33758847ChAdOx1 nCoV-19 (AZD1222) protects Syrian hamsters against SARS-CoV-2 B.1.351 and B.1.1.7.bioRxiv2021
34382034Subtle differences in the pathogenicity of SARS-CoV-2 variants of concern B.1.1.7 and B.1.351 in rhesus macaques.bioRxiv2021
34642697Year-long COVID-19 infection reveals within-host evolution of SARS-CoV-2 in a patient with B cell depletion.medRxiv2021
34465900Microbial signatures in the lower airways of mechanically ventilated COVID-19 patients associated with poor clinical outcome.Nat Microbiol2021
34578379Disruption of the Golgi Apparatus and Contribution of the Endoplasmic Reticulum to the SARS-CoV-2 Replication Complex.Viruses2021
34620866ChAdOx1 nCoV-19 (AZD1222) protects Syrian hamsters against SARS-CoV-2 B.1.351 and B.1.1.7.Nat Commun2021
34678071Subtle differences in the pathogenicity of SARS-CoV-2 variants of concern B.1.1.7 and B.1.351 in rhesus macaques.Sci Adv2021
34120579Prior aerosol infection with lineage A SARS-CoV-2 variant protects hamsters from disease, but not reinfection with B.1.351 SARS-CoV-2 variant.Emerg Microbes Infect2021
34111271Report of the National Institutes of Health SARS-CoV-2 Antiviral Therapeutics Summit.J Infect Dis2021
33431511Single-cell RNA sequencing reveals SARS-CoV-2 infection dynamics in lungs of African green monkeys.Sci Transl Med2021
33443221Reston virus causes severe respiratory disease in young domestic pigs.Proc Natl Acad Sci U S A2021
32511299Respiratory disease and virus shedding in rhesus macaques inoculated with SARS-CoV-2.bioRxiv2020
31784761A Novel Field-Deployable Method for Sequencing and Analyses of Henipavirus Genomes From Complex Samples on the MinION Platform.J Infect Dis2020
32054787Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection.Proc Natl Acad Sci U S A2020
31978293A Novel Coronavirus Emerging in China - Key Questions for Impact Assessment.N Engl J Med2020
33269345A betacoronavirus multiplex microsphere immunoassay detects early SARS-CoV-2 seroconversion and antibody cross reactions.Res Sq2020
33090972Hydroxychloroquine prophylaxis and treatment is ineffective in macaque and hamster SARS-CoV-2 disease models.JCI Insight2020
32577633Hydroxychloroquine Proves Ineffective in Hamsters and Macaques Infected with SARS-CoV-2.bioRxiv2020
32803199K18-hACE2 mice develop respiratory disease resembling severe COVID-19.bioRxiv2020
32731258ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques.Nature2020
32645325The Global Phosphorylation Landscape of SARS-CoV-2 Infection.Cell2020
32641430Nipah@20: Lessons Learned from Another Virus with Pandemic Potential.mSphere2020
32839775SARS-CoV-2 infection dynamics in lungs of African green monkeys.bioRxiv2020
32392321Twenty Years of Nipah Virus Research: Where Do We Go From Here?J Infect Dis2020
32182409Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1.N Engl J Med2020
32516797Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2.Nature2020
32396922Respiratory disease in rhesus macaques inoculated with SARS-CoV-2.Nature2020
  • 1 - 50 of 131

Recommended Authors

Center for Pathogen Research, University of Maryland School of Medicine
Career Start Year 2017
Number of shared co-authors 40
Icahn School of Medicine at Mount Sinai New York
Career Start Year 2015
Number of shared co-authors 20
College of Veterinary Medicine, Kansas State University
Career Start Year 2013
Number of shared co-authors 7
Campus de la Universitat Autonoma de Barcelona (UAB)
Career Start Year 2011
Number of shared co-authors 6
Stanford University School of Medicine
Career Start Year 2010
Number of shared co-authors 7
Sanford Burnham Prebys Medical Discovery Institute
Career Start Year 2010
Number of shared co-authors 8
University of Texas Medical Branch
Career Start Year 2009
Number of shared co-authors 5
Icahn School of Medicine at Mount Sinai
Career Start Year 2009
Number of shared co-authors 13
Center for Innate Immunity and Immune Disease, University of Washington
Career Start Year 2009
Number of shared co-authors 8
University of Texas Medical Branch
Career Start Year 2008
Number of shared co-authors 10
University of Texas Medical Branch
Career Start Year 2008
Number of shared co-authors 10
Rutgers University
Career Start Year 2007
Number of shared co-authors 4
University of Texas Medical Branch
Career Start Year 2007
Number of shared co-authors 5
National Center for Toxicological Research
Career Start Year 2005
Number of shared co-authors 5
Institute for Human Infection and Immunity, University of Texas Medical Branch
Career Start Year 2005
Number of shared co-authors 8
University of North Carolina
Career Start Year 2004
Number of shared co-authors 6
University of North Carolina at Chapel Hill
Career Start Year 2003
Number of shared co-authors 12
Korea University College of Medicine
Career Start Year 2001
Number of shared co-authors 3
University of North Carolina School of Medicine
Career Start Year 1999
Number of shared co-authors 9
The University of North Carolina at Chapel Hill
Career Start Year 1998
Number of shared co-authors 7
Icahn School of Medicine at Mount Sinai
Career Start Year 1996
Number of shared co-authors 48
Icahn School of Medicine at Mount Sinai
Career Start Year 1994
Number of shared co-authors 21
Center for Pathogen Research, University of Maryland School of Medicine
Career Start Year 1993
Number of shared co-authors 49
University of North Carolina at Chapel Hill
Career Start Year 1993
Number of shared co-authors 9
Geneva University Hospital
Career Start Year 1993
Number of shared co-authors 9
The University of Texas Medical Branch
Career Start Year 1991
Number of shared co-authors 4
University of North Carolina at Chapel Hill.
Career Start Year 1990
Number of shared co-authors 14
Centers for Disease Control and Prevention.
Career Start Year 1989
Number of shared co-authors 13
University of North Carolina
Career Start Year 1981
Number of shared co-authors 19
University of Texas Medical Branch at Galveston
Career Start Year 1970
Number of shared co-authors 12

Collaborators

National Institutes of Allergy and Infectious Disease, National Institutes of Health
Co-authored papers 14
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Co-authored papers 8
The Fenway Institute
Co-authored papers 7
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Co-authored papers 6
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Co-authored papers 6
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Co-authored papers 6
Section of Emergency Medicine,University of Nebraska Medical Center
Co-authored papers 6
National Institute of Allergy and Infectious Diseases
Co-authored papers 5
University of Texas Medical Branch
Co-authored papers 4
University of Manitoba
Co-authored papers 4
University of Washington
Co-authored papers 4
College of Veterinary Medicine, Kansas State University
Co-authored papers 3
US Centers for Disease Control and Prevention
Co-authored papers 3
Clinical Center (CC)
Co-authored papers 3
National Institute of Allergy and Infectious Diseases
Co-authored papers 3
Erasmus Medical Center
Co-authored papers 3
Center for Innate Immunity and Immune Disease, University of Washington
Co-authored papers 2
Centers for Disease Control and Prevention (CDC)
Co-authored papers 2
Icahn School of Medicine at Mount Sinai
Co-authored papers 2
Center for Cancer Research, National Cancer Institute
Co-authored papers 2
London School of Hygiene & Tropical Medicine
Co-authored papers 2
Graduate School of Medicine, The University of Tokyo
Co-authored papers 2
European Bioinformatics Institute (EMBL-EBI)
Co-authored papers 2
Co-authored papers 2
National Science Foundation
Co-authored papers 2
Infectious Disease Clinical Research Program, Uniformed Services University
Co-authored papers 2
Co-authored papers 1
Institute of Experimental Medicine and Systems Biology, RWTH Aachen University
Co-authored papers 1
University of Pennsylvania
Co-authored papers 1
J. David Gladstone Institutes
Co-authored papers 1